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Mohr MA, Vergales BD, Lee H, Clark MT, Lake DE,
Mennen AC, Kattwinkel J, Sinkin RA, Moorman JR, Fairchild
KD, Delos JB. Very long apnea events in preterm infants. J Appl
Physiol 118: 558 –568, 2015. First published December 30, 2014;
doi:10.1152/japplphysiol.00144.2014.—Apnea is nearly universal
among very low birth weight (VLBW) infants, and the associated
bradycardia and desaturation may have detrimental consequences. We
describe here very long (⬎60 s) central apnea events (VLAs) with
bradycardia and desaturation, discovered using a computerized detection system applied to our database of over 100 infant years of
electronic signals. Eighty-six VLAs occurred in 29 out of 335 VLBW
infants. Eighteen of the 29 infants had a clinical event or condition
possibly related to the VLA. Most VLAs occurred while infants were
on nasal continuous positive airway pressure, supplemental oxygen,
and caffeine. Apnea alarms on the bedside monitor activated in 66%
of events, on average 28 s after cessation of breathing. Bradycardia
alarms activated late, on average 64 s after cessation of breathing.
Before VLAs oxygen saturation was unusually high, and during VLAs
oxygen saturation and heart rate fell unusually slowly. We give
measures of the relative severity of VLAs and theoretical calculations
that describe the rate of decrease of oxygen saturation. A clinical
conclusion is that very long apnea (VLA) events with bradycardia and
desaturation are not rare. Apnea alarms failed to activate for about
one-third of VLAs. It appears that neonatal intensive care unit (NICU)
personnel respond quickly to bradycardia alarms but not consistently
to apnea alarms. We speculate that more reliable apnea detection
systems would improve patient safety in the NICU. A physiological
conclusion is that the slow decrease of oxygen saturation is consistent
with a physiological model based on assumed high values of initial
oxygen saturation.
apnea; neonatal; hypoxia; bradycardia
MORE THAN TWO DECADES AGO, Southall et al. (60) reported
prolonged apnea and bradycardia events in preterm infants
cared for in neonatal intensive care units (NICUs). In their
study of 14 babies observed for 24-h periods, the authors were
disturbed to report cessations of breathing as long as 213 s and
to report that extended apnea events were often not detected or
reported. Present practices (13, 18, 36) hold that any cessation
of breathing longer than 10 s, if accompanied by bradycardia
and oxygen desaturation, is an event that should be considered
clinically significant (as should any apnea longer than 20 s
regardless of bradycardia or desaturation). Most events last less
than half a minute, either self-resolving or terminating when a
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caregiver stimulates the infant in response to a monitor alarm.
Very long apnea (VLA) events may reflect abnormal physiology, impending illness, alarm failure, and/or failure of bedside
clinicians to rescue infants from prolonged apneic spells.
Nearly all very low birthweight infants (VLBW; ⬍1,500 g)
experience apnea due to inherent brainstem and peripheral
chemoreceptor immaturity, and pathologic processes such as
sepsis, respiratory failure, intracranial hemorrhage, and seizures may increase the number or severity of apnea events.
Apnea events may lead to tissue hypoxemia and, especially if
prolonged, severe, or frequent, might contribute to adverse
short- and long-term outcomes, including neurodevelopmental
impairment. Preventing or minimizing bradycardia and desaturation related to apnea should therefore be a priority in NICU
care. Steps toward this goal include understanding physiologic
associations with severe apnea and optimizing monitor alarm
systems and caregiver responses.
Apnea research was previously hindered by inaccurate and
inefficient recording of events. Our group recently developed
an automated apnea detection system that analyzes chest impedance (CI) waveform signals from all NICU bedside monitors, filters out cardiac and motion artifacts, and accurately
identifies central apnea events accompanied by bradycardia
and oxygen desaturation (ABD) (34). Using this novel system,
together with a database consisting of over 100 infant years of
electronic signals, we sought to quantitate and characterize
VLA events in VLBW infants, defined as cessation of breathing ⬎60 s accompanied by bradycardia (heart rate ⬍100
beats/min) and oxygen desaturation (SpO2 ⬍80%).
In this article we report descriptive clinical aspects and
quantitative physiological aspects of very long central apnea
events. We seek answers to the following questions. 1) Do
infants really stop breathing for more than 60 s? How frequent
are such events in our population? 2) Are the babies who have
VLAs in some way different from those who do not, or is it the
events that are different? 3) How significant are these events
for the health of the infants? 4) Why do these events still
occur? 5) We observe in these events very slow decline of heart
rate and oxygen saturation. Can we give a physiological
explanation for either of them? This article is organized such
that the primary clinical results are in the main text, and
everything mathematical is in APPENDIXES B–D.
Neonatal apnea has previously been addressed from a variety of perspectives: physiology of respiration (8, 25), apnea of
prematurity (6, 7, 13, 18, 27, 31, 35, 37, 41, 44, 46, 63), long
apnea events (1, 10, 30, 45, 61), failure of monitoring (9, 22,
39, 60, 62, 66), the effect of saturation on apnea (23, 24), and
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the effect of apnea on SpO2 and bradycardia (16, 20, 28, 42, 43,
57). However, no previous workers have had access to such a
large dataset (⬃100 infant years, 335 VLBW infants, ⬃20,000
apnea events), and none have connected clinical observations
to the quantitative physiological theory that we give in the
appendixes.
METHODS

Patients
We studied all 335 VLBW (⬍1,500 g) infants admitted from
January 2009 through March 2011 to the 45 bed University of
Virginia (UVa) NICU, a quaternary care facility that has more than
500 admissions per year, about one quarter of them VLBW. The study
was approved by the UVa Institutional Review Board with waiver of
consent and subsequently by the William and Mary Protection of
Human Subjects Committee.
Bedside Monitor Data Collection
We collected and stored all waveform, vital sign, and alarm data
from all NICU bedside monitors (GE Medical, models Solar 8000M
and I and Dash 3000) via a BedMaster central network server (Excel
Medical, Jupiter, FL). CI waveforms were collected at 60 Hz, three
channels of electrocardiogram waveforms were collected at 240 Hz,
and the photoplethysmographic waveform was collected at 120 Hz. In
addition, vital sign data (heart rate, CI-derived respiratory rate, and
pulse oximetry-derived O2 saturation recorded every 2 s) were collected. Also, all bedside monitor alarms were collected. Bradycardia
alarms sound when the heart rate goes below a set limit (typically 90
beats/min) for at least eight heartbeats, oxygen alarms sound when
SpO2 is lower than a set limit (typically 85%) for at least 5 s, and apnea
alarms sound after 15 s of no monitor-detected breaths in the CI
signal.

Identification of VLAs
In VLBW infants the computer algorithm identified 461 very long
central apnea events (ⱖ60 s) accompanied by bradycardia and desaturation in which all waveforms were available in VLBW infants.
Every such event was examined by at least two clinicians who are
expert on interpretation of the signals. Two groups of two clinicians
independently reviewed half of the candidate VLA events, followed
by consensus review in equivocal cases. It was found that some
algorithmically detected events were artifacts caused by weak signals.
In many other cases, the CI waveform signal was not completely flat
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but had some small or brief fluctuation that might represent one or
several shallow breaths. Such events appear to be clinically relevant,
and we discuss them in APPENDIX A. Here, however, we wish to focus
on the less common indisputable events. Candidate events were
accepted as VLAs only if there was an acceptable CI tracing before,
during, and after the event, the event was accompanied by any
duration of bradycardia (⬍100 beats/min) and desaturation (⬍80%),
the cessation of breathing lasted at least 60 s, and the filtered CI had
no artifacts, no indication of shallow breaths, and no twitches in CI
having an associated increase in heart rate. With this stringent process,
86 VLA events were identified in 29 infants (Fig. 1A and APPENDIX A).
Study Group (I) and Comparison Group (N)
The result of this validation was that algorithmically-detected
ABD60 events were divided into three categories: 1) VLAs, which we
regard as indisputable cessations of breathing of 60 s or more; 2)
“questionable” 60-s events involving, for example, long apnea-hypopnea combinations, which we regard as clinically significant but not
indisputable VLAs (discussed in APPENDIX A); and 3) excluded events.
The same process identified the study group (I), consisting of those 29
infants who had “Indisputable” events. We chose a comparison group
(N), consisting of those infants whose electronic signals “Never”
showed a 60-s event of any type, validated, questionable, or excluded.
In RESULTS we compare apnea rates and other characteristics of these

A
150bpm
100bpm
80%
50%

Apnea Analysis
We previously developed and validated a new algorithm for detecting central apnea (34). The algorithm filters the cardiac artifact and
low-frequency fluctuations from the CI signal, analyzes the residual
fluctuations, and produces, at quarter-second intervals, the probability
that the infant is having a central apnea event at that moment. Careful
validation indicated that the algorithm agrees with the expert opinion
of clinicians in ⬃90% of central apnea events. For the current
analysis, we focused on central apnea events associated with bradycardia and desaturation. The algorithm’s threshold for bradycardia is
a heart rate ⬍100 beats/min and for oxygen desaturation SpO2 ⬍80%,
for any duration. The events are categorized as ABDn, with “n”
signifying the minimum length of cessation of breathing in seconds
(e.g., ABD60 means cessation of breathing was 60 s or more, and
ABD30 – 40 means cessation of breathing was between 30 and 40 s).
For all infants in our database, we have recorded the date, time, and
duration of every ABD10 event (10 s or more). Those ABD60 events
that survived the validation described below are called VLAs.
We also collected several random samples of 10- to 20-s and 30- to
40-s apnea events to compare their properties with those of VLAs.
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Fig. 1. A: an example of a very long apnea (VLA). Shown are raw and
processed electronic signals collected from bedside monitors. From top to
bottom: heart rate from monitor, 100 beat/min threshold for bradycardia,
oxygen saturation and 80% threshold for desaturation, raw chest impedance
(CI), and filtered CI (removing cardiac artifact and slow fluctuation). Bottom
curve is probability that the infant is having an apnea at each moment. This
VLA lasts slightly more than 60 s. B: example of an apnea event lasting at least
60 s accompanied by bradycardia and oxygen desaturation (ABD60) that was
excluded in our conservative validation. The small waves in the CI signal
followed by an increase in heart rate might have been small breaths.
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Table 1. Infant characteristics
Gestational age, wk
Birth weight, g
ELBW
Male
Mechanical ventilation at any time
Death before NICU discharge
Length of NICU stay, days

A

VLA (n ⫽ 29)

No VLA (n ⫽ 306)

P⫽

26.5 ⫾ 1.9
952 ⫾ 249
19 (66%)
14 (48%)
23 (79%)
1 (3%)
78 ⫾ 27

27.5 ⫾ 3.1
988 ⫾ 299
150 (49%)
154 (50%)
214 (70%)
31 (10%)
63 ⫾ 42

0.09
0.53
0.12
0.85
0.39
0.34
0.02

RESULTS

Patient Characteristics and Clinical Associations
Data from 335 VLBW infants were analyzed, and 86 VLA
events in 29 infants were validated by the process described in
METHODS and in APPENDIX A. The estimated frequency of these
VLA events is 1 per 70 infant days. (If questionable events
were included, the estimate of the frequency would be about
four times larger; see APPENDIX A.) Characteristics of the infants
are given in Table 1. The number of events per infant ranged
from 1 to 19 (Fig. 2). In most respects, infants with VLAs were
not significantly different from other VLBW infants (Table 1).
Infants with VLA events had significantly longer NICU stays
Number of VLAs by Infant

Number of VLAs (86 total)

19

# of VLBWs
# of events
# of infants

10
0

number of VLAs

23

25

26
27
28
GA (weeks)

29

30

30

31

VLBW infants
VLA events

300

20

200

10

100

0

0

2

4
age (weeks)
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8

0

Fig. 3. A: histogram of number of VLA events and number of VLA infants vs.
gestational age (GA) at birth. For comparison the number of infants vs. GA for
the entire population of very low birth weight (VLBW) infants in our database
is also shown. For example, among 26-wk GA infants, 8 of the 37 VLBW
infants had at least 1 event, and there were 15 total events. B: histogram of
number of VLA events vs. chronological age (CA) at time of event for those
infants having 1 or more VLAs (left scale). For comparison the number of
VLBW infants who were in the University of Virginia neonatal intensive care
unit (NICU) at that CA is also shown (right scale). For example, at 1 wk of
age, there were 25 VLAs among 266 VLBW infants.

than those without (P ⫽ 0.02), and their average gestational
age was slightly lower (P ⫽ 0.09; Table 1). Over half of the
VLA infants fell in the gestational age (GA) range of 25–27 wk
(Fig. 3A) and 84% of VLAs occurred ⬍4 wk from birth (Fig.
3B). Seventy-nine percent of the VLAs occurred while infants
were on continuous positive airway pressure (CPAP), usually
with supplemental oxygen (Fig. 4). All 29 infants were on
caffeine therapy at some time during their NICU stay, one

60

Infants with clinical associations
Infants with no clinical associations

24

number of VLBW infants

Demographic data collected from the medical record included
gestational age at birth, postmenstrual age (PMA) at the time of
events, birthweight, and gender. Respiratory data collected from the
medical record included the type of respiratory support, supplemental
oxygen, administration of caffeine (if any), and the time on and off
respiratory support. Times on mechanical ventilation were excluded.
Clinical conditions or events potentially associated with VLA events
were recorded, including severe intraventricular hemorrhage, severe
gastroesophageal reflux, suspected sepsis (cultures obtained and antibiotics initiated within 24 h of VLA), respiratory failure (intubation
and mechanical ventilation within 12 h after the VLA), and death.
Survival to NICU discharge and length of NICU stay were recorded.
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B
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30

VLA, very long apnea; ELBW, extremely low birth weight; NICU, neonatal
intensive care unit.

groups. (We also report the number of infants who never had a
computer-detected ABD10.)

•

50
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# of infants

40
30
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0
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1
1

4

7

10

13 16
Infant

19

22

25

28

Fig. 2. Number of VLA events per infant (infant 1 had 19 events, and 29
infants had at least 1 event).

Room Air

NC

NC
CPAP
sup O2

CPAP
sup O2

Fig. 4. Histogram showing respiratory support of VLA infants at the times of
their events. From left to right: room air, nasal cannula (NC) without supplemental oxygen (sup O2), nasal cannula with supplemental oxygen, continuous
positive airway pressure (CPAP) without supplemental oxygen, and CPAP
with supplemental oxygen. Most VLA events occurred while infants were on
CPAP with supplemental oxygen.
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#Infants

Clinical Association

GA

#VLAs

PMA

1
1

Died 48 h after last VLA
Posthemorrhagic hydrocephalus,
ventricular tap performed
before VLA cluster
Grade IV intraventricular
hemorrhage
On prostaglandins for
congenital heart disease
On medication for severe GE
reflux
Antibiotics started for suspected
sepsis within 24 h of VLA
Receiving antibiotics at time of
event
Intubated within 12 h of VLA
None identified, other than
prematurity

27
26

19
3

28–32
31

26

2

30

29

3

31

25

3–12

27–29

23–29

1–19

26–31

25–30

1–19

25–32

23–29
24–31

1–4
1–5

24–31
27–34

1
2
4
10
7
11
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Apnea Rates in Different Groups of Infants

Table 2. Clinical conditions

1

•

GA, gestational age; PMA, postmenstrual age; GE, gastroesophageal.

VLA occurred 4 days after caffeine was discontinued. Two
infants had VLA on the day of birth, before caffeine being
initiated. No VLA events occurred within 10 days of NICU
discharge.
For 18 of the 29 infants with VLAs, medical record review
identified clinical conditions (separate from prematurity, which
was present in all subjects), which are possibly associated with
apnea (Table 2). Ten infants were receiving antibiotics at the
time of the VLA, four were started on antibiotics within 24 h
of the VLA for suspected sepsis (although none had proven
septicemia), seven were intubated within 12 h of the VLA, and
six had other conditions. The infant with the greatest number of
events (19) died suddenly and unexpectedly for unclear reasons. He was stable on full feeds, CPAP, and caffeine at the
time of death, and autopsy was declined. The other infant with
a large number of events (12 VLAs at 2–3 wk of age) was on
erythromycin for severe gastroesophageal reflux. No VLAs
occurred beyond 18 days of age, and he was discharged home
at 78 days of age. We could see no systematic differences in
the characteristics of the VLAs associated with these different
clinical situations.
For the other 11 infants (38% of the VLA infants), we could
not identify a clinical condition that appeared to be a cause or
effect or to have an association with the VLA. These 11 differ
only slightly from the 18 with clinical associations. The infants
without clinical associations had slightly higher GAs, but the
difference was not significant (P ⫽ 0.16). Not surprisingly,
these 11 infants also had shorter stays in the NICU than the
other 18 infants (P ⫽ 0.02). There were no differences in the
rate of fall of heart rate and SpO2 between VLA infants with
clinical associations and those without.

ABD10 tags in our database identify every computer-detected cessation of breathing lasting at least 10 s, when also
accompanied by bradycardia and desaturation. The majority of
VLBW infants in our population never had any computerdetected 60-s ABD event (group N). This group of infants had
a low rate of short apnea events, and 31% of them never
had even an ABD10 event. On the other hand, infants who had
indisputable VLAs (group I) also had many short apnea events.
The total number of ABD10 tags for the study group (I) and the
comparison group (N) of VLBW infants are in Table 3.
Included in the 199 infants in group N are 62 infants who
never had a computer-detected apnea lasting at least 10 s with
bradycardia and desaturation (ABD10). Thus in our population, 81% of VLBWs had at least one detected ABD10, while
19% did not.
Bedside Monitor Alarms in VLA Events
Apnea alarms are supposed to activate 15 s from the beginning of cessation of breathing; in fact they activated in 66% of
these VLAs but failed to activate in 34% of them. Since
bradycardia alarms activated in 57% of VLAs, and low oxygen
alarms activated in 81%, the end result is that at least one alarm
activated in 97% of VLAs. The monitors and the algorithm use
slightly different criteria for bradycardia and desaturation, so it
is not surprising that these alarms did not go off during all VLA
events. (For additional comparisons among algorithm detection, monitor alarms, and nursing records, see Ref. 66.)
For the cases in which the bedside monitor gave an apnea or
bradycardia alarm, Fig. 5 shows histograms of lengths of time
from the start of the computer-detected apnea to the alarm and
of times from the alarm to the end of the detected apnea. If an
apnea alarm activated, it did so rather promptly, usually ⬍25 s
from the beginning of the computer-detected apnea. If a bradycardia alarm sounded, it usually occurred long after the
cessation of breathing (Fig. 5), consistent with the slow fall of
heart rate in these events. Shortly after the bradycardia alarm
sounded (but frequently quite long after the apnea alarm), the
apnea ended. We do not know which events were self-resolved
and which were ended by staff response, but this observation is
consistent with many others that suggest that NICU personnel
respond quickly to bradycardia alarms and not necessarily to
apnea alarms (9, 22, 39, 60, 62, 66).
Characteristics of Short Apnea Events in Infants with and
without VLA
To determine whether short apnea events in infants who
have VLAs are different from short apnea events in other
infants we collected a random sample of 100 ABD30 – 40

Table 3. Study group characteristics
Groups

Number of
ABD10 Tags

Number of
Infants

%All VLBW
Babies

Tags per Baby-Day
of Data

Group I: infants with indisputable 60-s VLAs
Group N: infants who Never had a ABD60
Infants who never had a computer-detected ABD10 (included in group N)
All VLBW infants

6,617
6,300
0
30,793

29
199
62
335

9
59
19
100

4.29
1.52
0
2.94

ABD, apnea events accompanied by bradycardia and oxygen desaturation.
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43, 57). The median oxygen saturations in the 60 s before the
apnea begins are 92% for ABD10 –20 events; 93% for
ABD30 – 40 events; 96% for VLAs in which apnea lasts from
60 to 80 s; and 97% for VLAs where apnea lasts longer than
80 s. Oxygen saturations before VLAs was significantly greater
than saturation before the shorter apnea events (Wilcoxon
rank-sum, P ⬍⬍ 0.001).
Additional details about the rate of fall of SpO2 are given in
APPENDEXES B–D. 1) Because of the slow fall, it is not immediately clear whether the severity of apnea events increases in
proportion to their duration; measures of severity of apnea
events of various durations are discussed in APPENDIX B, and we
conclude that the duration is indeed a fair measure of the deficit
of oxygen transported in the blood. 2) In APPENDIX C, we show
that before a VLA, the infants are, on average, breathing
slightly faster than they are before a short apnea, and we show
that the median SpO2 is gradually rising in the 5 min before the
VLA. 3) A quantitative theory for the rate of fall of SpO2 is
given in APPENDIX D; the results of this theoretical calculation
are shown in Fig. 7.
DISCUSSION

0

20

40
60
80
100
time from alarm to end of apnea

120

Fig. 5. Time from cessation of breathing to bedside apnea or bradycardia alarm
(A), and time from alarm to end of apnea for VLAs (B). If the apnea alarm
sounds, it usually does so within ⬃20 s after the beginning of the apnea. In
VLA events, the heart rate falls slowly, so the bradycardia alarm is much
delayed, typically sounding 60 –70 s after the apnea begins. Apneas usually
end a short time after the bradycardia alarm.

events from our study group (I) and also from our comparison
group (N). Events for this comparison group were chosen such
that infants’ PMA at the time of the event was ⬍34 wk and
there was no apnea in the 5 min preceding the ABD30 – 40
event.
In Fig. 6 we show the average heart rate and oxygen
saturation for these 100 events in each group. There is no
statistically significant difference between these two groups in
the rate of fall of oxygen saturation or heart rate. The same
holds for ABD10 –20 events. In this regard there is no difference between VLA infants and non-VLA infants.
Comparison of Short and Long Events in Infants Having
VLAs
A striking characteristic of the long apnea events is that the
heart rate and oxygen saturation fall later and more slowly
compared with the decline in heart rate and SpO2 during shorter
ABD events. This is shown in Fig. 7; 100 ABD 10 –20 and 100
ABD 30 – 40 events were randomly selected only from infants
who had indisputable VLAs (group I). The events were chosen
such that the infant’s PMA was ⬍31 wk at the time of the
event. The average of multiple events is plotted, and the
standard error of the means is marked. The heart rate fell below
100 beats/min and the oxygen saturation fell below 80% in
every individual event. However, these thresholds were
crossed at different times in different events, so the averages do
not necessarily fall below the thresholds.
Just before the VLA begins, the oxygen saturation is significantly higher than the saturation before shorter ABDs (other
somewhat related studies include Refs. 16, 20, 23, 24, 28, 42,

While apnea is a normal developmental phenomenon in
preterm infants, exaggerated apnea is an important problem
that may reflect or lead to adverse events or outcomes. These
events are interesting from a physiologic perspective and
important from a patient safety perspective; thus we turn to the
questions posed in the Introduction.
1) How frequent are the events? VLA events are not rare.
We used very stringent criteria to define a VLA. We found that
infants show no evidence of breathing for durations of up to
132 s. These events occur with a frequency of 1 per 70 infant
days in our population.
2) Are the infants with VLA different? VLA infants differ
from non-VLA infants in that they have a much higher rate of
short apnea events and presumably have less developed respiratory control. We found short apnea events in VLA infants to
be indistinguishable from short apnea events in non-VLA
infants.
3) How clinically significant are the events? It is difficult to
establish the effect of VLAs on the short-term or long-term
health of infants. In APPENDIX B we show that, despite the slow
drop of SpO2 in VLAs, the available measure of deficit in
oxygen transport is approximately proportional to the duration
160

Group I

140

heart rate (bpm)

120

Group N

100
80
60

Group N
Group I

SpO

2

0
50
100
150
time from start of apnea (seconds)

Fig. 6. Average heart rate and oxygen saturation in a random selection of 100
ABD30 – 40 events in infants who had indisputable VLAs (group I) and infants
of comparable PMA who never had an ABD60 (group N). SpO2, oxygen
saturation. Vertical lines indicate ⫾ 1SE.
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Prolonged apnea events should be preventable. Since these
events could have detrimental consequences and are often not
noticed and/or not recorded in the medical record, improvements in bedside monitor apnea detection, alarm systems, and
caregiver responses are key to providing a safer environment
for hospitalized preterm infants.
APPENDIX A: QUESTIONABLE AND EXCLUDED EVENTS
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at the commencement of the event (see Comparison of Short
and Long Events in Infants Having VLAs and APPENDIX C).
Combining this observation with the hypothesis that venous
oxygen is also somewhat elevated leads to a quantitative
description of the average rate of fall of SpO2 with time
(presented in APPENDIX D).

heart rate

120bpm

•

120

Fig. 7. In VLAs oxygen saturation and heart rate fall slowly. We show the
average heart rate and SpO2 for all of the VLAs (ABD60 – 80, n ⫽ 46, and
ABD80, n ⫽ 40). For the shorter events we took a random sample of
ABD10 –20 (n ⫽ 100) and ABD30 – 40 (n ⫽ 100) from this same group of
infants. The start of the computer-detected apnea is t ⫽ 0. The black curves,
barely distinguishable from the observed SpO2 curves, are based on the theory
from Eqs. 1– 6 with constants given in Table D1. Vertical lines indicate ⫾ 1SE.

of the cessation of breathing, i.e., 90-s apnea events result in
approximately three times the oxygen transport deficit of 30-s
apnea events (which are already considered by some to be
“extreme”; Ref. 30). Our information on clinical consequences
leads to ambiguous results. On one end of the VLA spectrum,
an apparently healthy preterm infant had 19 events over a 3-wk
period and eventually died following a respiratory arrest from
which he could not be resuscitated. However, other VLA
infants had normal courses in the NICU. Lacking postdischarge objective neurodevelopmental follow-up testing on infants, we can only say that, with the possible exception of the
infant who died, no clinical consequences could be proved to
be caused by VLAs. Nevertheless, VLAs cannot be good for
infants, and their frequency is disturbing.
4) Why do VLAs occur? Part of the explanation of why
VLAs occur is that apnea alarms fail to activate in about
one-third of these events. In addition, we previously showed
that about two-thirds of all apnea alarms are false alarms (34),
so alarm fatigue or alarm distrust may also be a factor (66).
Clinical experience and our data suggest that bedside caregivers respond quickly to bradycardia alarms, which are “crisis”
alarms on the monitors in the UVa NICU (in contrast to apnea
“warning” alarms), but as a result of the slow fall of heart rate
these alarms are delayed. We believe that more reliable apnea
alarms, with fewer false negatives and false positives, would be
helpful to NICU personnel and might have a significant beneficial effect on the health of infants by reducing hypoxemia
and bradycardia.
5) What is the physiological mechanism? We show that the
respiratory rate is somewhat elevated and SpO2 steadily rises in
the 5 min before a VLA. Accordingly, SpO2 is unusually high

Clinicians reviewed 461 ABD60 events in VLBW infants for
which all waveforms were available. Of these, 20 had poor and
uninterpretable signals, and 38 were recognized as apnea events of
less than a 60-s duration. These 58 events were excluded. The
remaining 317 events failed our strict VLA criteria for the following
reasons: there were fluctuations in the CI with a frequency lower than
typical breathing, the origin of these fluctuations is unknown, but they
certainly do not represent normal breathing; there were small shallow
breaths present (hypopnea); the event was actually two separate apnea
events; or there was a small wave in the CI which was followed by a
rise in the heart rate. In Fig. 1B the two small fluctuations in the CI are
followed by an increase in heart rate, so they are possibly small
breaths and this event was excluded.
We consider these 317 “questionable” cases to be examples of
failure of respiratory regulation lasting at least 60 s, but we do not
include them in our category of indisputable VLAs. If these 317
events have clinical significance comparable to that of the indisputable VLAs, then the total number of events is more than four times
larger than stated in Patient Characteristics and Clinical Associations,
i.e., 1 per 16 infant days in our population.
APPENDIX B: MEASURES OF SEVERITY OF A VLA

A balanced perspective on the significance of VLAs is needed. One
difficulty in assessing their impact arises from the slow fall in oxygen
saturation and heart rate during these events; consequently, it is not
clear that the duration of the apnea is a good measure of the severity
of a VLA. Indeed, Alvarro and Rigatto (2) suggested that “The length
of the respiratory pause is not a very useful indicator of [its] severity.
. . . For this reason, many centers . . . have decided to rely on heart rate
as the primary indicator of severity.” Furthermore, the optimal oxygen
saturation for infants is a matter of current debate (4, 5, 11, 15, 40, 53,
58, 59, 65, 70).
To compare VLAs with shorter apnea events, we defined and
computed measures of the oxygen deficit and the heartbeat deficit.
These measures are areas on graphs of SpO2 or heart rate vs. time.
Method
Clinicians note the depth and the duration of desaturation events.
However, automated data analysis systems could provide superior
measures, for example, the area enclosed by the SpO2 curve below a
chosen threshold. This area is related to the deficit in the quantity of
oxygen carried by the blood. If normal oxygen transport in the blood
is M ml/min, and the measured area under the baseline is A % min,
then M·A/100 is the oxygen deficit resulting from the apnea. For
example, if normal transport were 5 ml O2/min (Ref. 14, p. 970), then
an area of 22% min means that over the duration of the apnea event,
the blood transported 1.1 ml of O2 less than it would have in the
absence of the apnea.
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(0.18%·min·s⫺1), but the correlation coefficient is comparable (0.79,
P ⬍⬍ 0.001).

The area obtained depends on the baseline chosen. We choose our
baseline to be the lesser of 92% or a measured preapnea baseline
(PAB). That PAB was obtained by evaluating the mean  and
standard deviation  of SpO2 over an interval before the long event and
taking PAB ⫽ -2. The interval was chosen to be within 120 s of the
beginning of the VLA but not containing another desaturation with an
area greater than 2% min. An example is shown in Fig. B1A, with an
area of 22% min.
The depth and duration of an associated bradycardia are relevant
measures of the severity of an apnea event, but again an area measure
is more appropriate. For each event, we chose a baseline from the
heart rate before the apnea, mean minus two standard deviations over
an interval within 120 s from the cessation of breathing but not
containing a drop of more than 10 beats/min. We calculate the area
between that baseline and the actual heart rate while the heart rate is
below the baseline. This area is the heartbeat deficit, the number of
heartbeats that the infant would have had if its heart rate continued at
the baseline value minus the actual number of beats. In Fig. B1A this
baseline is shown and the area below the baseline in this case amounts
to a deficit of 85 beats.

Discussion
The graphs in Fig. B1B show measures of the relative significance
of VLAs vs. short apnea events. The roughly linear trend suggests that
a 90-s apnea results in about three times the oxygen deficit and three
times the heartbeat deficit of a 30-s apnea. (This fact is not obvious a
priori, because heart rate and SpO2 decrease slowly in long apnea
events.) Such deficits could be reduced by earlier and more accurate
identification of apnea events.
APPENDIX C: OXYGENATION BEFORE VLAS

Here we give evidence that infants are raising the oxygen level in
their blood before a VLA. 1) We show that those infants who have
VLAs breathe more rapidly before a VLA than before a short apnea.
2) We show that the median SpO2 rises gradually in the minutes before
a VLA.
Method
The respiration rate reported by monitors is notoriously unreliable
because of artifacts in the CI signal. Using our filtered CI (34), from
which most artifacts have been removed, we found zero-crossings of
the filtered CI and maxima and minima between each zero-crossing.
We define the breath length to be the time between two successive
minima. To prevent residual fluctuations around zero to be mistakenly
interpreted as breaths, we applied two additional criteria. 1) The
probability of apnea must be less than 0.5 at the times of the minima.
2) Consecutive maxima and minima must be at least 0.1 times the
standard deviation of the signal.
We examined apnea events only in those infants who have VLAs.
We obtained the respiration rate for 100 breaths preceding each of the
86 VLAs and also for 100 breaths preceding 100 randomly selected
apnea events of duration 10 –20 s in the same infants.

Results
We examined long and short apnea events in “Infant 1,” the infant
who had 19 VLAs. Random sets of ABD10 –20 and ABD30 – 40
events from this infant were collected. With the use of the method
described above, the “oxygen deficit” and the “heartbeat deficit” were
calculated in these shorter events and in the 19 VLAs. The results are
shown in Fig. B1B. The areas increase approximately linearly with the
duration of the apnea. The sample correlation coefficients are 0.81 for
heart rate (P ⬍⬍ 0.001) and 0.88 for oxygen saturation (P ⬍⬍
0.001). This indicates that the area measure is providing some information independent of the duration, but area and duration are well
correlated.
Lower baselines give smaller areas. A baseline of 80% for oxygen
saturation gives a slope that is about half of what our baseline gave
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Fig. B1. Methods for measuring severity of apneas. A: for each
signal, a baseline is chosen. For heart rate the mean minus two
standard deviations in an interval before the apnea that contains
no significant deceleration is chosen as a baseline. For SpO2 the
lower of a similar baseline or 92% is used. The areas between
the chosen baseline and the signal are computed. In this case
the VLA is followed by short events, and after reaching a
minimum, SpO2 rises and falls again. We include only the area
up to the marked boundary, at the local max of SpO2. B: oxygen
deficit (O2) and heartbeat deficit (HR) vs. apnea duration for 1
infant, with linear fits using the least squares method. For HR
the linear fit is A ⫽ 0.64T-14.79 and the correlation coefficient
is 0.81. For O2 the linear fit is A ⫽ 0.33T-2.6 and the
correlation coefficient is 0.88.
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values of SpO2 correspond to values at which the oxygen-hemoglobin
dissociation curve SpO2(PO2) is flat; as oxygen is absorbed from
alveoli into blood, and the partial pressure of oxygen in the alveoli
falls, the associated drop in arterial oxygen saturation is small. Here
we give a quantitative model that shows this effect.

The best way to make the comparison is with the cumulative
histograms of breath lengths (Fig. C1A). This shows for each duration
T the fraction of breaths having duration less than T. That curve was
fit to a rational function of T, and the derivative of that rational
function was computed, giving what we call the continuous-fit histogram.
For SpO2 we calculated the median in the 5 min leading up to the
86 VLAs and in the 5 min leading up to the same randomly selected
apnea events of 10- to 20-s duration (Fig. C1B).

Method
An excellent study of the theory of arterial oxygen desaturation
during apnea in preterm infants was carried out by Sands et al. (50),
following a long tradition of closely related work (17, 25, 32, 38, 54,
55, 64, 68, 69) (see also Refs. 48, 49, 51, 52, 67). We use this as the
basis for the following theory which we compare with our observations. The assumptions and approximations used are 1) during an
apnea, the only loss of oxygen in the alveoli arises from diffusion into
the blood. 2) In each heartbeat, gaseous oxygen in the alveoli equilibrates with oxygen in pulmonary capillaries. 3) Venous blood is
homogeneous, with uniform SpO2. 4) The oxygen saturation in the
pulmonary vein leaving the lungs is equal to the oxygen saturation
measured by the pulse oximeter a few seconds later, in the finger or
toe. 5) All O2 in the blood is carried by hemoglobin. 6) During the
apnea, the cardiac output does not change significantly. 7) SpO2 is
related to partial pressure of oxygen in the alveoli by an equation first
given by Hill (29) and quoted (with a slight change) by DelivoriaPapadopoulos and McGowan (14)

Result
The resulting graphs are shown in Fig. C1. From the cumulative
histograms it is clear that the breath durations leading up to a VLA are
generally shorter than those leading up to a 10- to 20-s apnea.
Comparing the two distributions using the Kolmogorov-Smirnov test
gives a P value of 0.0024, confirming that the two distributions are
different. Barely visible behind the cumulative distributions in Fig.
C1A is a smooth curve representing the rational-function fit. The
derivatives of these, the continuous-fit histograms, are also shown.
Breaths before VLAs are on average 3% shorter, in median 3.3%
shorter, and in mode 9% shorter than breaths before 10- to 20-s apnea
events.
Also we see that median SpO2 rises gradually in the 5 min leading
up to VLAs.

n
n
⁄ 1 ⫹ kPO
SpO2 ⫽ 100kPO
2 共
2兲

APPENDIX D: A MATHEMATICAL MODEL FOR THE RATE
OF DECLINE OF SPO2

(1)

In this equation, we took n ⫽ 2.9 (14) and calculated k from
reasonable values of P50, the value of pressure at which SpO2 ⫽ 50%.
These assumptions lead to two differential equations with a time
delay:

Here we present the theory represented by the theoretical curves in
Fig. 7 showing SpO2 as a function of time. The most striking fact about
the VLAs is that oxygen saturation falls more slowly in these events
than in shorter apnea events (Fig. 7). Why does this happen? We
propose that the explanation of the slow fall of SpO2 is that both
arterial and venous oxygenation are unusually high at the start of the
event. The high value of venous saturation (Sv) causes the partial
pressure of oxygen in the alveoli to drop rather slowly. The high initial
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ABD10 –20 events in the same infants. B: median SpO2 in the
5 min leading up to a VLA for the 46 ABD60 – 80 events and
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Fig. D1. An example of oxygen saturation falling in 2 stages. SpO2, filtered CI,
and the probability of apnea are shown.

Equation 2 is equivalent to Eq. 10 of Sands et al. (50), and Eq. 3 can
be derived from Eq. 6 in Sands et al. Here S(t) is the oxygen saturation
leaving the lungs, which by assumption is equal to the measured SpO2
a few seconds later; Sv(t) ⫽ SvO2, the venous oxygen saturation, C is
a constant, proportional to hemoglobin concentration in the blood and
to the cardiac output and inversely proportional to lung volume, and
D(S) ⫽ dSpO2 ⁄ dPO2

(4)

which can be obtained from Eq. 1, and which must be expressed as a
function of SpO2 rather than PO2. T is arterial transit time, d is equal
to cardiac output divided by venous blood volume, and e is the rate at
which oxygen is utilized by the tissues. We treat C, T, d, and e as
constants, independent of time, and independent of the duration of the
apnea event. From their values, and from the initial conditions S(t ⫽
0) and Sv(t ⫽ 0), the above equations determine the evolution of S(t).
These four constants and the initial conditions were determined by
first obtaining preliminary estimates and then refining by fitting to the
observations. The preliminary estimates were obtained by the following process. Sands et al. (50) showed that oxygen saturation during an
apnea frequently follows a two-stage pattern. In the first stage, t ⱕ T,
S(t) drops rapidly, while in the second stage, it drops more slowly and
at a constant rate (Fig. D1). In cases where the two stages can be easily
identified on a graph of S(t) the arterial transit time T can be
determined from the graph. Also, in the first stage Sv(t) is constant.
Hence in this stage, Eq. 2 contains two unknowns: Sv and C. These
can be determined by choosing two points in time early in the apnea,
tj ⫽ (t1, t2), extracting S(tj) and dS/dt|tj from the observations, and then
solving the two equations for C and Sv.
To obtain estimates of d and e we set t ⫽ T in Eq. 3 and find
d关S(0) ⫺ SV(T)兴 ⫺ e ⫽ d关S共0兲 ⫺ SV(0)兴 ⫺ e ⫽ 0

(5)

In the second stage, the arterial oxygen saturation falls linearly with
time at a rate approximately equal to (50)
dS(t) ⁄ dt ⬇ ⫺e ⁄ (1 ⫹ dT)
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Finally, the values of these parameters were adjusted to fit the
observations.

SpO2

1

•

Results
It is very important to note that we used the same constant values
of C, T, d, and e for short and long apnea events. We adjusted only the
initial conditions S(0) and Sv(0) to fit the individual curves.
Table D1 lists the constants (except e, which can be found using
Eq. 5) and the initial conditions. The resulting theoretical curves are
shown in Fig. 7. The agreement with the average SpO2 curves is
remarkable: over the whole of each of the ranges where SpO2 is
falling, the theoretical curves are only barely discernible from the
observed ones and differ from them by less than the standard error of
the means of the observations.
In parentheses in Table D1 we report the uncertainty in the values
of the parameters. These were obtained by finding the standard
deviation of the mean of each set of observations and adjusting
parameters one-at-a-time to find values where the theoretical curves
would disagree with observations by more than one standard error of
the mean.
Discussion
We have shown that the theory given by Sands et al. (50) leads to
remarkable agreement with observation. Thereby, it provides a credible explanation of why SpO2(t) falls slowly in long apnea events
(whereas other attempted explanations fail). Two factors are at work.
At high oxygen saturations, the curve relating oxygen saturation to
partial pressure of oxygen SpO2(PO2) is flat, and the function D(S) is
near zero. In the alveoli and in the arteries, a large change in partial
pressure of oxygen gives only a small change in SpO2. As a result,
SpO2 falls very slowly near the beginning of an apnea when oxygen
saturation is high. In this regard the slow fall of SpO2 from high levels
is a natural consequence of well-known physiology. The second factor
is the inferred somewhat elevated oxygen saturation in the veins. We
have no direct measurements of venous oxygen saturation; it is
obtained only by fitting to the observations. However, this is consistent with the result shown in APPENDIX C showing the steady rise of
SpO2 over at least 5 min before VLAs.
Assumptions and approximations. To understand the limits of the
theory (50) as we apply it, let us reexamine some of the approximations. During an apnea, the CO2 concentration and pH of the blood
may change, and these shift the hemoglobin saturation curve,
SpO2(PO2). This shift can be characterized by a changed value of P50,
the pressure at which hemoglobin is 50% saturated. This change,
however, turns out to have only a small effect on the time dependence
SpO2(t). One can include the effect approximately by changing the
value of k in Eq. 1. However, when calculating SpO2(t) as described
above using Eq. 1, the value of k exactly cancels (for fixed C and
SvO2), so at this level of approximation, P50 has no effect. [In a more
accurate treatment, again holding C and SvO2 fixed, P50 would have a
nonzero but small effect; Sands et al. (50), who used the Severinghaus
formula (56) instead of Eq. 1, found that a change of P50 by 6 –12

(6)

From the observed rate of decline dS(t)/dt in the second stage, and
with Sv(0) determined as above from stage 1, we have two equations
for d and e with two unknowns.
Two issues remain. 1) There is a time delay between oxygen
leaving the lungs and oxygen detected in the finger or toe. Part of this
time delay is related to circulation time of blood and part of it is
related to the averaging time of the oxygen monitor. A time delay of
20 s was chosen for all of the average curves in Fig. 7 and gave
satisfactory results. 2) The average saturation curves do not show any
clear division between stage 1 and stage 2. Therefore, individual
apnea events that show this distinction were used to obtain estimates
of T, d, and e. There are several such cases, one of which is shown in
Fig. D1.

Table D1. Initial conditions and constants. Values in
parentheses were obtained using the one-at-a-time method
Parameter

ABD10–20

S
Sv
C
d
T

0.870 (0.005)
0.70 (0.01)

ABD30–40

ABD60–80 (VLAs)

0.915 (0.007)
0.950 (0.005)
0.74 (0.01)
0.800 (0.005)
13.3 (0.6)
0.2 (0.6)
12 (1)

ABD80 (VLAs)

0.970 (0.003)
0.825 (0.005)

S, saturation; Sv, venous saturation; C, constant proportional to hemoglobin
concentration in the blood and to the cardiac output and inversely proportional
to lung volume; d, cardiac output divided by venous blood volume; T, arterial
transit time.
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mmHg gave significant changes to SpO2(t), but part of the change they
obtained resulted from changed initial values of SpO2 and SvO2.]
Another effect we neglected is extrapulmonary right-to-left shunt.
Since we find that the median oxygen saturation before a VLA is
96 –98%, it appears that shunted blood is a small fraction of arterial
blood and would have little effect on the calculation of SpO2(t). Sands
et al. (50) also note that shunt fraction affects the starting value of
SpO2(t) but has little effect on its rate of change.
Cardiac output was assumed to be approximately constant. This
approximation is commonly used in models of short apnea events and
models of periodic breathing (32, 38, 64), and it can be justified as a
manifestation of the Frank-Starling effect (25), which is now known
to be present in neonates (3, 20, 33, 47).
Further study of assumption (3), that venous blood is well-mixed
and homogeneously oxygenated would be beneficial. This should be
accurate in steady state, but it is not clear that it would hold during the
rapid changes of oxygenation that occur during apnea.
Alternative hypotheses. We arrived at this theory only after elimination of a number of other hypotheses, which we examine here. 1)
Infants who have VLAs are different in some way from other infants
of comparable age. For example, they may have unusually high
amounts of fetal hemoglobin, which holds oxygen more strongly than
adult hemoglobin, and therefore oxygen saturation may drop more
slowly when they have apnea. However, this hypothesis can be
excluded, because these same infants (in the same epochs) have short
apnea events that are indistinguishable from short apnea events in
other infants. 2) There is some mechanism acting in some instances
that, analogous to the “diving seal” reflex, reduces oxygen consumption in these infants. This hypothesis is not credible because these
events look nothing like the dive reflex. This reflex acts within
seconds; one observation of the dive reflex in a human infant showed
the heart rate dropping from ⬎150 to ⬍105 beats/min in ⬃1 s (21).
Furthermore, reduced oxygen consumption would affect venous oxygen saturation, which would slow the rate of fall of arterial oxygen
only after a time delay, but we see arterial oxygen saturation falling
slowly from the beginning. 3) Noting that most of the infants who
have VLAs are on CPAP, one might hypothesize that the infant is
somehow getting oxygen from the CPAP even though there is no
detectable chest movement. CPAP is expected to maintain functional
residual capacity; in this regard, this hypothesis is consistent with the
model presented above. In addition, one might hypothesize that CPAP
is providing a flow of fresh air to the alveoli that is not visible in the
CI signal (12). “Apneic oxygenation” is flow of fresh air into alveoli
caused by removal of oxygen into the blood stream (19, 26). Rough
estimates suggest that this process would have a small effect. We have
no decisive evidence for or against this hypothesis, but it does not
explain why the same infant in the same epochs has short apnea events
in which oxygenation falls quickly and long ones in which it falls
slowly. Also, a quantitative theory of this process is not presently
available, it would be complex, and it would depend on a number of
unknown parameters. In contrast, the theory given in Sands et al. (50)
and applied above is fully developed, and we can extract all parameters by fitting to observations.
Conclusion
This theoretical method might turn out to provide useful physiological information. C and d are both proportional to cardiac output,
e is proportional to metabolic rate, and Sv is the venous oxygen
saturation, none of which are continuously available in NICU monitoring. By fitting the time course of SpO2 in individual apnea events to
the theory, it may be possible to get estimates of these parameters
during each apnea. This will be the topic of a future study.
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